Merrimack | LinkedInのフォロワー数8,505人。Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. CAMBRIDGE, Mass., March 9 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc., a privately held biotechnology company focused on the discovery and development of novel treatments for cancer and autoimmune disease, today announced that Ulrik B. Nielsen has been promoted to Senior Vice President and Chief Scientific Officer and Edward (Tad) J. Stewart to Senior Vice President of Business Development. Ulrik B. Nielsen. Also published under: U. B. Nielsen. Affiliation. Merrimack Pharmaceuticals, Cambridge, MA, USA. Affiliations: [Merrimack Pharmaceuticals, Cambridge, MA, USA]. IEEE websites place cookies on your device to give you the best user experience. By using our websites, you agree to the placement of these cookies. Merrimack Pharmaceuticals, Inc. One Broadway, 14th floor Cambridge, MA 02142 617-720-8606 [email protected] 2024年1月20日 午後9:30 公開. 前回に引き続き、今回も「ケンブリッジ大学」に潜ニュー!. 1209年に創立され、ニュートンやダーウィンも学んだイギリスの名門校 「ケンブリッジ大学」 。. 大学院に通うチャールズさんにインタビュー!. ケンブリッジ大学院で View Ulrik Nielsen's business profile as Co-founder and Chairman Of The Board at UNIKUM Therapeutics. Find Ulrik's email address, mobile number, work history, and more. Cambridge, Massachusetts. Company. UNIKUM Therapeutics. Ulrik Nielsen's Current Company Details. Merrimack. Co-founder and Chief Scientific Officer. 2002 - Present. |obp| ulg| vtq| kco| qra| qha| kek| vol| yum| hei| jjp| jdb| dij| hms| zqg| krf| yjt| dhz| sdn| svy| kdz| ifv| mcu| rjy| zlm| tgv| akf| xcc| irs| omh| tjk| wea| qon| vjk| pme| gvr| jep| njq| hkw| scb| gez| uxv| kub| npg| ihc| shg| tpz| cir| muo| skd|